A New Jersey-based healthcare company turned heads on Tuesday following HC Wainwright & Co. maintaining a buy rating while raising its price target from $7 to $10/share. This...

To read the full story on AllPennyStocks.com, click here.

Protalix BioTherapeutics (AMEX:PLX)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024 Click aqui para mais gráficos Protalix BioTherapeutics.
Protalix BioTherapeutics (AMEX:PLX)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024 Click aqui para mais gráficos Protalix BioTherapeutics.